Labetuzumab govitecan T25593
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Labetuzumab govitecan is an anti-CEACAM5/SN-38 antibody-drug conjugate for therapy of refractory or relapsing metastatic colorectal cancer.
CAS nr:
1469876-18-3
Purity:
98%
Molecular Weight:
1587,76
SMILES:
CCc1c(Cn(c2cc3c4COC([C@]3(OC(OCc5ccc(NC([C@@H](NC(COCC(NCCOCCOCCOCCOCCOCCOCCOCCOCCn6nnc(CNC(C7CCC(CN8C(CC(SC[C@H](N)C(O)=O)C8=O)=O)CC7)=O)c6)=O)=O)CCCN)=O)cc5)=O)CC)=O)c4=O)c2nc9c1cc(O)cc9
Formula:
C75H102N12O24S
Pathway:
Target:
